SCHEMBL13622184

SCHEMBL13622184

COc1cc2c(c(OC)c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(=O)c1cccc(N(C)C)c1)CC2

nearest known ligand 0.78

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 13/20 0.78
TUBB4A P04350 12/20 0.78
TUBB P07437 12/20 0.78
TUBA3C P0DPH7 12/20 0.78
TUBA1B P68363 12/20 0.78
TUBA4A P68366 12/20 0.78
TUBB4B P68371 12/20 0.78
TUBB3 Q13509 12/20 0.78
TUBB2A Q13885 12/20 0.78
TUBB8 Q3ZCM7 12/20 0.78
TUBA3E Q6PEY2 12/20 0.78
TUBA1A Q71U36 12/20 0.78
TUBA1C Q9BQE3 12/20 0.78
TUBB6 Q9BUF5 12/20 0.78
TUBB2B Q9BVA1 12/20 0.78
HDAC3 O15379 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC2 Q92769 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13438471 0.93 TUBB4A (0.87) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622254 0.91 TUBB1 (0.83) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622177 0.90 TUBB4A (0.81) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1401451 0.90 TUBB4A (0.81) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13438472 0.89 TUBB4A (0.93) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1401534 0.88 TUBB4A (0.78) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1401466 0.87 TUBB4A (0.77) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1401535 0.87 TUBB4A (0.77) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1401578 0.85 TUBB1 (0.74) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13438470 0.85 TUBB4A (0.84) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021427-A1 Novel tricyclic derivatives and their use NFATC1, IL2, CCL2 TUBB1 14/4885TUBB4A 45/4885TUBB 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.